2023

Reading frequency:551  Updated on:2023-07-24

★ Chiheal Biomed completed its Series A financing, further strengthening its investment in R&D. The CRO, CMO, and CDMO models became increasingly mature. The first fast-follow innovative drug completed a transfer transaction.

PREV: 2022
NEXT: Taiji Group